Blood-based biomarkers including metabolites and proteins may be important in disease. We wish to use conventional and cutting-edge analyses to better understand the role that these biomarkers have in disease. We also want to better understand the relationship of genetic variants combined into a score exhibit with biomarkers and disease.
